New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study - Clinical Gastroenterology and Hepatology
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Libraries Back Pharmacist Pharmacist CE LibraryMTM Certificate ProgramVeterinary Pharmacy Certificate ProgramLaw Library for PharmacistsMedication Safety for Pharmacists Pharmacy Technician Pharmacy Technician LibraryMTM Certificate Program ...
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
When to stop, how to reverse, and when to restart antithrombotic drugs periendoscopically in nonvariceal upper gastrointestinal bleeding - Techniques and Innovations in Gastrointestinal Endoscopy
GI bleeding more common with rivaroxaban than other direct oral anticoagulants
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study - Gastroenterology
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
Through Thick and Thin: approaches to anticoagulant Reversal - ppt video online download
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME
Management of anticoagulation in patients with acute gastrointestinal bleeding - ScienceDirect
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study | The BMJ
ESC 2015 Meeting Report
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
